Literature DB >> 15687100

Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex.

Emmanouil Karteris1, Rachel J Machado, Jing Chen, Sevasti Zervou, Edward W Hillhouse, Harpal S Randeva.   

Abstract

Although starvation-induced biochemical and metabolic changes are perceived by the hypothalamus, the adrenal gland plays a key role in the integration of metabolic activity and energy balance, implicating feeding as a major synchronizer of rhythms in the hypothalamic-pituitary-adrenal (HPA) axis. Given that orexins are involved in regulating food intake and activating the HPA axis, we hypothesized that food deprivation, an acute challenge to the systems that regulate energy balance, should elicit changes in orexin receptor signaling at the hypothalamic and adrenal levels. Food deprivation induced orexin type 1 (OX1R) and 2 (OX2R) receptors at mRNA and protein levels in the hypothalamus, in addition to a fivefold increase in prepro-orexin mRNA. Cleaved peptides OR-A and OR-B are also elevated at the protein level. Interestingly, adrenal OX1R and OX2R levels were significantly reduced in food-deprived animals, whereas there was no expression of prepro-orexin in the adrenal gland in either state. Food deprivation exerted a differential effect on OXR-G protein coupling. In the hypothalamus of food deprived rats compared with controls, a significant increase in coupling of orexin receptors to Gq, Gs, and Go was demonstrated, whereas coupling to Gi was relatively less. However, in the adrenal cortex of the food-deprived animal, there was decreased coupling of orexin receptors to Gs, Go, and Gq and increased coupling to Gi. Subsequent second-messenger studies (cAMP/IP3) have supported these findings. Our data indicate that food deprivation has differential effects on orexin receptor expression and their signaling characteristics at the hypothalamic and adrenocortical levels. These findings suggest orexins as potential metabolic regulators within the HPA axis both centrally and peripherally.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15687100     DOI: 10.1152/ajpendo.00351.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  31 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

Review 2.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

3.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 4.  Food for thought: the role of appetitive peptides in age-related cognitive decline.

Authors:  Jim R Fadel; Corinne G Jolivalt; Lawrence P Reagan
Journal:  Ageing Res Rev       Date:  2013-02-13       Impact factor: 10.895

Review 5.  Role of orexin receptors in obesity: from cellular to behavioral evidence.

Authors:  C E Perez-Leighton; T A Butterick-Peterson; C J Billington; C M Kotz
Journal:  Int J Obes (Lond)       Date:  2012-03-06       Impact factor: 5.095

Review 6.  Orexin: pathways to obesity resistance?

Authors:  Tammy A Butterick; Charles J Billington; Catherine M Kotz; Joshua P Nixon
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

7.  OX1 orexin/hypocretin receptor activation of phospholipase D.

Authors:  M H Jäntti; J Putula; P Somerharju; M A Frohman; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 8.  Orexin/hypocretin receptor signalling cascades.

Authors:  J P Kukkonen; C S Leonard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

9.  Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala.

Authors:  David H Arendt; James Hassell; Hao Li; Justin K Achua; Douglas J Guarnieri; Ralph J Dileone; Patrick J Ronan; Cliff H Summers
Journal:  Psychoneuroendocrinology       Date:  2013-10-30       Impact factor: 4.905

Review 10.  Role of Orexin-A in Hypertension and Obesity.

Authors:  Roberta Imperatore; Letizia Palomba; Luigia Cristino
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.